Clinical Trials in Pittsburgh

Showing 5041-5060 of 21,047 trials

Psychosocial and Behavioral Intervention for Stem Cell Transplant Patients and Their Family Caregivers

NCT07107165

Adherence to the medical regimen after stem cell transplant is challenging for both patients and their family caregivers. The investigators propose a randomized clinical trial testing two brief psychosocial interventions to determine if either improves patient and family caregiver psychosocial and health-related outcomes.

Stem Cell TransplantHematopoetic Stem Cell TransplantHematopoetic Stem Cell Transplantation

University of Pittsburgh208 participantsStarted Jul 2025

Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 2< 1 mile

The Symptomatic Cerebral Cavernous Malformation Trial of REC-994

NCT05085561

This is a two-part, multi-center, randomized, double-blind, placebo-controlled study to investigate the safety, efficacy and pharmacokinetics of REC-994 (200 mg and 400 mg) compared to placebo in participants with symptomatic cerebral cavernous malformation (CCM).

Cerebral Cavernous Malformation

Recursion Pharmaceuticals Inc.62 participantsStarted Mar 2022

Phoenix, Arizona, United States • Los Angeles, California, United States • Palo Alto, California, United States +12 more locations

Psychosocial and Behavioral Intervention for Stem Cell Transplant Patients and Their Family Caregivers

The Symptomatic Cerebral Cavernous Malformation Trial of REC-994

Find Trials by Condition in Pittsburgh

An Extension Study of HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Idursulfase-IT in Conjunction With Elaprase in Pediatric Participants With Hunter Syndrome and Cognitive Impairment

Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003)

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis

Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection

OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD)

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate

A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Screening for AL Amyloidosis in Smoldering Multiple Myeloma

Identification of microRNAs Involved in Cerebral Collateral Regulation

HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide

A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)

A Study of GC012F (AZD0120), a CAR T Therapy Targeting CD19 and BCMA in Subjects With Relapsed/Refractory Multiple Myeloma

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration

Proton Re-Irradiation for Recurrent Head and Neck Cancer

Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer